One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study.

Niki ChristouMuriel MathonnetSébastien GaujouxGuillaume CadiotSophie DeguelteJean-Louis KraimpsJean-Christophe LifanteFabrice MenegauxEric MiralliéFabrice MuscariBruno CarnailleFrançois PattouAlain SauvanetPierre Goudet

Published in: World journal of surgery (2020)

Surgery and uncontrolled secretions remain the two main causes of death in MEN1 patients operated for a GPD-NET tumor. Improving the prognosis of these patients requires a strict evaluation of the secretory syndrome and MEN1 aggressiveness before GDP surgery.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
minimally invasive
peritoneal dialysis
type diabetes
cardiovascular disease
risk factors
patients undergoing
acute coronary syndrome
neuroendocrine tumors
patient reported outcomes
atrial fibrillation